Emis Dividends - EMIS

Emis Dividends - EMIS

Buy
Sell
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Emis Group Plc EMIS London Ordinary Share GB00B61D1Y04 ORD 1P
  Price Change Price Change % Stock Price Last Trade
-6.00 -0.56% 1,066.00 16:35:11
Open Price Low Price High Price Close Price Previous Close
1,056.00 1,050.00 1,064.00 1,066.00 1,072.00
more quote information »
Industry Sector
SOFTWARE & COMPUTER SERVICES

Emis EMIS Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
09/09/2020InterimGBX15.631/12/201931/12/202008/10/202009/10/202005/11/20200
18/03/2020FinalGBX15.631/12/201831/12/201913/04/202014/04/202011/05/202031.2
30/08/2019InterimGBX15.631/12/201831/12/201926/09/201927/09/201901/11/20190
20/03/2019FinalGBX14.231/12/201731/12/201811/04/201912/04/201913/05/201928.4
31/08/2018InterimGBX14.231/12/201731/12/201827/09/201828/09/201802/11/20180
14/03/2018FinalGBX12.931/12/201631/12/201702/04/201803/04/201804/05/201825.8
01/09/2017InterimGBX12.931/12/201631/12/201721/09/201722/09/201727/10/20170
16/03/2017FinalGBX11.731/12/201531/12/201630/03/201731/03/201703/05/201723.4
02/09/2016InterimGBX11.731/12/201531/12/201622/09/201623/09/201628/10/20160
16/03/2016FinalGBX10.631/12/201431/12/201531/03/201601/04/201629/04/201621.2
04/09/2015InterimGBX10.631/12/201431/12/201524/09/201525/09/201530/10/20150
19/03/2015FinalGBX9.231/12/201331/12/201409/04/201510/04/201501/05/201518.4
05/09/2014InterimGBX9.231/12/201331/12/201424/09/201426/09/201431/10/20140
20/03/2014FinalGBX831/12/201231/12/201309/04/201411/04/201402/05/201416
06/09/2013InterimGBX831/12/201231/12/201325/09/201327/09/201331/10/20130
21/03/2013FinalGBX7.131/12/201131/12/201217/04/201319/04/201303/05/201314.2
31/08/2012InterimGBX7.131/12/201131/12/201219/09/201221/09/201226/10/20120
16/03/2012FinalGBX6.231/12/201031/12/201111/04/201213/04/201230/04/201212.4
02/09/2011InterimGBX6.231/12/201031/12/201114/09/201116/09/201121/10/20110
18/03/2011FinalGBX5.631/12/200931/12/201024/04/201126/04/201130/05/201111.2
14/09/2010InterimGBX5.631/12/200931/12/201022/09/201024/09/201025/10/20100

Top Dividend Posts

DateSubject
20/11/2020
09:48
wad collector: Agree the recent share price drop seems surprising in a rising market . It didn't tumble down at the beginning of Covid,(except for a transient overreaction) for obvious reasons , but it is disappointing not to be still falling . However EMIS is one I don't lose sleep over ; it will be here next decade unless it is taken over.
13/10/2020
19:23
thewheeliedealer: Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast a few days ago and part of our discussion includes EMIS and our take on increasing need for effective IT in the NHS and government. We also chatted about loads of other Stocks and some Ideas for research, and the outlook for Markets and as usual a fair bit of educational stuff with regards to Investing. Anyway, if you use Apple, Audioboom, Overcast or Spotify you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 33) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, Cheers, WD @wheeliedealer hTTps://soundcloud.com/user-479955511/conkers3-wheeliedealer-33-risks-of-herding-cine-boo-dddd-itm-lxi-sre-inl-ai-av-aaz
15/9/2020
12:55
undervaluedassets: NIce boring, sustainable yield here too; the divi has been raised every year since 2011.
11/9/2020
12:04
wad collector: Well it is moving out of its 6 month trading range now , not sure about the 4 yr range. Happy to see it cross £12 again , but it doesn't really matter much to me as I don't plan on selling these for yrs. The market is not in the mood for takeovers at the moment but not out of the question in the next few yrs given its secure very position in a deep niche. I work with EMIS daily and there would be a lot of unhappy primary care staff if we were forced to use another system, given many of us have used it for almost 3 decades and have seen the disruption caused just by changing to a new Emis version . It is not their only product but it is the main one.
10/9/2020
09:37
tomps2: EMIS Group Plc (EMIS) H1 2020 presentation to analysts, 9th September 2020, by Andy Thorburn, CEO & Peter Southby, CFO. Video: Https://www.piworld.co.uk/2020/09/10/emis-group-plc-emis-half-year-2020-results-presentation/ Podcast: Https://www.piworld.co.uk/podcasts/
09/9/2020
16:11
energeticbacker: Emis isn’t the most exciting of technology plays, this is a consistent performer with plenty of reliable recurring revenue, generating attractive operating margins and return on equity, and the new EXA suite offers interesting growth potential. More on the Investor's Champion website.
09/9/2020
15:43
undervaluedassets: Re results today.. Despite robust rises in Reported EPS, profit and cash. Emis were conservative choosing only to raise the divi modestly. So the dividend cover has gone up.which I like.
09/9/2020
14:39
energeticbacker: The net operating cash inflow was an impressive £28.8m, although this was flattered by £7.3m of VAT payments deferred until 2021 – with a substantial cash buffer one wonders why they didn’t just pay the VAT. Free cash flow was £26.3m and they ended the period with net cash of £44.1m, supporting a 3% increase in the interim dividend to 16.0p per share. More on the Investor's Champion website.
09/9/2020
11:27
rathlindri: Excellent gains today, on the back of a solid set of figures. Well done Emis!
21/5/2019
09:11
wad collector: New ATH today as it passes £12. I see there was an IC buy article last week; In January 2018, a disappointing announcement from Emis (EMIS) sent its shares plunging. The group – a provider of connected healthcare software and services – had identified “a failure to meet certain service levels and reporting obligations” with its customer NHS Digital, following a review conducted by new chief executive Andy Thorburn. The final numbers for 2017 – issued a couple of months later – reflected in a £11.2m provision, taken to cover the potential financial settlement and remedial expenses. A solemn note on which to start. But, since then, Emis has given cause for increasing optimism – helping to lift its shares to a recent all-time high. For one thing, it settled with NHS Digital – ultimately paying out £1.7m less than expected. Now, the government’s £450m ‘GP IT Futures framework’ could be a catalyst for growth. This aims to “create an open, competitive market to encourage the best technology companies to invest in the NHS”. It replaces the current framework, ‘GP Systems of Choice’ (GPSoC), which currently represents the largest single source of revenue for Emis. True, there’s a risk that it won’t be included on the new framework. Upon reviewing its latest preliminary numbers, we retained a ‘hold’ call – explaining that we’d rather monitor the procurement process from the sidelines. But we now see grounds for encouragement as the procurement phase begins, including Mr Thorburn's purchase of £50,000-worth of shares last month at 1,131p. Emis, which is currently market leader in GP software, thinks it is well positioned in the pre-procurement phase, especially given its “strategy and roadmap for a new and enhanced cloud-based clinical platform” (named Emis-X), which “further aligns the group with NHS England's strategy”. Last week's AGM statement provided further reassurance. “Pre-procurement engagement with NHS Digital continues positively, with the formal GP IT Futures procurement process expected to begin in the coming weeks”. According to NHS Digital, procurement will begin shortly with the issue of tender invitations. Existing arrangements under the GPSoC framework will end by December 2019. The new arrangements will then be in place for all practices across England. Meanwhile, high levels of recurring revenue constitute a feather in Emis’s cap. For 2018, these rose by 5 per cent to £141m – representing 83 per cent of the top line, in keeping with the prior year. Meanwhile, reported operating profits should be taken with a small pinch of salt, having been flattered by 2017’s (overgenerous) provision charge. But adjusted profits still edged up 1 per cent. Another plus point for Emis is its solid cash generation. Adjusted cash from operations climbed by a tenth to £54.5m for the respective period, supporting a decent dividend hike and providing money to invest in the group's growth plans. The cash position will also get a boost from the sale of Emis's non-core specialist and care division for £14.9m, which was announced a few weeks ago.
ADVFN Advertorial
Your Recent History
LSE
EMIS
Emis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210307 10:33:24